Novo Nordisk A/S

Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…

U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters Novo Nordisk said on…

A FedEx worker walks past his truck in the North Beach neighborhood on June 23, 2026 in San…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

This medical device stock looks like a gift for patient investors